2 results
Approved WMOPending
To evaluate the efficacy and safety of nilotinib in spondyloarthritis
Approved WMOCompleted
Double-blinded part:The primary objectives of the study are as follows:• To investigate the safety and tolerability of 28 days of oral doses of SAR443060 in subjects with ALS.The secondary objectives of the study are as follows: • To characterize…